Literature DB >> 10633236

Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry.

Z Wang1, C E Hop, K H Leung, J Pang.   

Abstract

Studying the permeability of compounds across a Caco-2 cell monolayer is an established in vitro model to screen for oral absorption and to evaluate the mechanism of transport. This assay can also be used to evaluate compounds as potential P-glycoprotein substrates and/or inhibitors. The traditional methods of sample analysis (high-performance liquid chromatography (HPLC) with a UV or fluorescence detector) limit the throughput and sensitivity of this assay. Data are presented here describing the use of liquid chromatography/tandem mass spectrometry (LC/MS/MS) for the analysis of samples derived from the Caco-2 cell studies. During the analysis an automatic switching valve was used to divert the flow from the HPLC column to waste for the first minute, preventing the early eluting salts from entering and contaminating the LC/MS interface. This approach allows the rapid and accurate determination of drug transport across the Caco-2 cell monolayer. The high sensitivity and specificity of LC/MS/MS make this technique an ideal candidate for the low concentration and high throughput routine analysis of Caco-2 cell solutions, especially if multiple compounds are administered and analyzed simultaneously. Thus, the use of LC/MS/MS will increase the value of the Caco-2 cell assay as an in vitro screening tool. Copyright 2000 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2000        PMID: 10633236     DOI: 10.1002/(SICI)1096-9888(200001)35:1<71::AID-JMS915>3.0.CO;2-5

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  13 in total

1.  Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis.

Authors:  Jochem Alsenz; E Haenel
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

Review 2.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

3.  Discovery of 1H-Pyrazole Biaryl Sulfonamides as Novel G2019S-LRRK2 Kinase Inhibitors.

Authors:  Robert K Leśniak; R Jeremy Nichols; Marcus Schonemann; Jing Zhao; Chandresh R Gajera; Grace Lam; Khanh C Nguyen; J William Langston; Mark Smith; Thomas J Montine
Journal:  ACS Med Chem Lett       Date:  2022-05-23       Impact factor: 4.632

4.  Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

Authors:  Adam Smith; Brian Giunta; Paula C Bickford; Michael Fountain; Jun Tan; R Douglas Shytle
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

5.  N-in-one permeability studies of heterogeneous sets of compounds across Caco-2 cell monolayers.

Authors:  Leena Laitinen; Heli Kangas; Ann Marie Kaukonen; Kati Hakala; Tapio Kotiaho; Risto Kostiainen; Jouni Hirvonen
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

6.  Human Primary Cell-Based Organotypic Microtissues for Modeling Small Intestinal Drug Absorption.

Authors:  Seyoum Ayehunie; Tim Landry; Zachary Stevens; Alex Armento; Patrick Hayden; Mitchell Klausner
Journal:  Pharm Res       Date:  2018-02-23       Impact factor: 4.200

7.  Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034.

Authors:  K-C Cheng; Walter A Korfmacher; Ronald E White; F George Njoroge
Journal:  Perspect Medicin Chem       Date:  2007-06-26

8.  An antimycobacterial pleuromutilin analogue effective against dormant bacilli.

Authors:  Maddie R Lemieux; Shajila Siricilla; Katsuhiko Mitachi; Shakiba Eslamimehr; Yuehong Wang; Dong Yang; Jeffrey D Pressly; Ying Kong; Frank Park; Scott G Franzblau; Michio Kurosu
Journal:  Bioorg Med Chem       Date:  2018-08-18       Impact factor: 3.641

9.  Crystal engineering of green tea epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats.

Authors:  Adam J Smith; Padmini Kavuru; Kapildev K Arora; Sheshanka Kesani; Jun Tan; Michael J Zaworotko; R Douglas Shytle
Journal:  Mol Pharm       Date:  2013-06-26       Impact factor: 4.939

10.  Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia.

Authors:  Xingjian Li; Daniel T Payne; Badarinath Ampolu; Nicholas Bland; Jane T Brown; Mark J Dutton; Catherine A Fitton; Abigail Gulliver; Lee Hale; Daniel Hamza; Geraint Jones; Rebecca Lane; Andrew G Leach; Louise Male; Elena G Merisor; Michael J Morton; Alex S Quy; Ruth Roberts; Rosanna Scarll; Timothy Schulz-Utermoehl; Tatjana Stankovic; Brett Stevenson; John S Fossey; Angelo Agathanggelou
Journal:  Medchemcomm       Date:  2019-08-01       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.